Last €3.52 EUR
Change Today -0.02 / -0.56%
Volume 28.0K
ALNEV On Other Exchanges
Symbol
Exchange
EN Paris
Frankfurt
As of 11:35 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

neovacs (ALNEV) Snapshot

Open
€3.55
Previous Close
€3.54
Day High
€3.58
Day Low
€3.51
52 Week High
02/25/14 - €4.40
52 Week Low
11/20/13 - €1.59
Market Cap
69.4M
Average Volume 10 Days
115.0K
EPS TTM
€-0.35
Shares Outstanding
19.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NEOVACS (ALNEV)

Related News

No related news articles were found.

neovacs (ALNEV) Related Businessweek News

No Related Businessweek News Found

neovacs (ALNEV) Details

Neovacs S.A., a biotechnology company, focuses on active immunotherapy for autoimmune and inflammatory diseases in France. The company’s product pipeline comprises tumor necrosis factor kinoid for the treatment of rheumatoid arthritis and Crohn’s diseases; interferon a-kinoid to treat lupus; and vascular endothelial growth factor kinoid for the treatment of macular degeneration and cancer. Neovacs S.A. is based in Paris, France.

20 Employees
Last Reported Date: 04/30/14

neovacs (ALNEV) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

neovacs (ALNEV) Key Developments

NEOVACS Names Nathalie Thomas-Pujol Head of Regulatory Affairs

NEOVACS announced the appointment of Nathalie Thomas-Pujol as head of regulatory affairs. In her new role, she will ensure that Neovacs' preclinical and clinical development plans are compliant with international regulatory requirements.

Neovacs S.A. Presents at 2014 Asia Biotech Invest Conference, Jun-05-2014 11:50 AM

Neovacs S.A. Presents at 2014 Asia Biotech Invest Conference, Jun-05-2014 11:50 AM. Venue: Sheraton Hong Kong Hotel & Towers, 20 Nathan Road, Kowloon, Hong Kong. Speakers: Miguel Sieler, Chief Executive Officer.

Neovacs S.A., Annual General Meeting, May 19, 2014

Neovacs S.A., Annual General Meeting, May 19, 2014., at 10:00 Central European Standard Time. Location: 3/5 impasse Reille.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALNEV:FP €3.52 EUR -0.02

ALNEV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALNEV.
View Industry Companies
 

Industry Analysis

ALNEV

Industry Average

Valuation ALNEV Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2,215.0x
Price/Book 17.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2,046.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOVACS, please visit www.neovacs.fr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.